Cosmo N.V. GAAP EPS of -€0.28, revenue of €50.24M
Seeking Alpha ·
Cosmo N.V. press release ( CMOPF ): 1H GAAP EPS of -€0.28. Revenue of €50.24M (-2.9% Y/Y), while recurring revenue grew 18% YoY to reach €49.58M. Cash, cash equivalents, and short-term investments totaled €205.15M .
AI 시장 분석
Cosmo N.V. reported 1H GAAP EPS of -0.28 EUR and revenue of 50.24 million EUR, representing a 2.9% decrease year-over-year. However, recurring revenue showed robust growth, increasing by 18% to 49.58 million EUR. In addition, the company maintained financial stability by securing 205.15 million EUR in cash and short-term investments. Investors should focus on the high growth of recurring revenue and abundant cash flow rather than the decline in total revenue.
상승 영향
- Biotech — Recurring revenue increased by 18%, proving the stable growth of the core business, and abundant cash equivalents exceeding 200 million EUR defend against downside pressure.
하락 영향
- Biotech — GAAP EPS recorded a deficit at -0.28 EUR and total revenue decreased by 2.9% year-over-year, raising concerns about a short-term earnings slowdown.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 47% · Bearish (Short) 53%
352 participants
Related News
- Ryder forecasts 2026 comparable EPS of $14.40-$14.80 as used vehicle gains outlook rises to about $40M
- Quest Diagnostics projects $11.95B-$12.05B 2026 revenue while raising EPS outlook again
- First Industrial lifts 2026 NAREIT FFO outlook to $3.08-$3.16 as it starts a $77M Philadelphia development
- First Resource Bank GAAP EPS of $0.92, revenue of $8.53M
- StandardAero selected by GE to support engines for U.K. military helicopter fleet
- OpenAI says Health in ChatGPT now available to US users
